CannTrust (TSE:TRST) had its target price lowered by research analysts at Eight Capital from C$4.00 to C$2.00 in a report issued on Wednesday, BayStreet.CA reports. Eight Capital’s target price points to a potential downside of 30.31% from the stock’s current price.
Other research analysts have also recently issued research reports about the company. Jefferies Financial Group decreased their price target on CannTrust from C$15.00 to C$13.00 in a research note on Friday, May 3rd. Canaccord Genuity decreased their price target on CannTrust from C$5.00 to C$2.50 and set a “hold” rating for the company in a research note on Friday, July 26th. Cormark cut CannTrust from a “buy” rating to a “market perform” rating and set a C$7.00 price target for the company. in a research note on Tuesday, July 9th. Finally, Bank of America reissued a “buy” rating and issued a C$11.00 price target on shares of CannTrust in a research note on Friday, May 24th.
TRST traded down C$0.04 during trading on Wednesday, reaching C$2.87. 699,837 shares of the company were exchanged, compared to its average volume of 2,184,620. CannTrust has a 52 week low of C$2.45 and a 52 week high of C$15.50. The firm has a market capitalization of $403.79 million and a PE ratio of -23.80. The business’s 50 day moving average price is C$4.69. The company has a debt-to-equity ratio of 8.20, a quick ratio of 1.90 and a current ratio of 5.64.
CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.
Featured Story: What is meant by buying and selling pressure?
Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.